Insider Trading March 11, 2026

Natera Executive Sells Shares to Cover RSU Taxes After Company Posts Strong Quarter

President John Fesko disposes of 707 shares while the company reports robust Q4 2025 revenue and attracts analyst attention

By Sofia Navarro NTRA
Natera Executive Sells Shares to Cover RSU Taxes After Company Posts Strong Quarter
NTRA

John Fesko, President and Chief Business Officer of Natera, sold 707 shares on March 10, 2026, at $204.1327 per share to meet tax obligations tied to vested RSUs, reducing his direct stake to 189,199 shares. The transaction followed the issuance of 1,774 fully-vested RSU shares on March 9. Natera reported $666 million in revenue for Q4 2025, beating expectations, and drew reaffirmed and adjusted analyst price targets from Canaccord Genuity and Morgan Stanley.

Key Points

  • John Fesko sold 707 Natera shares on March 10, 2026, at $204.1327 per share, totaling about $144,321.
  • The sale reduced Fesko's direct ownership to 189,199 shares and was executed to cover tax obligations from RSU vesting; he also received 1,774 fully-vested RSU shares on March 9, 2026.
  • Natera reported Q4 2025 revenue of $666 million, beating the $590.72 million consensus (a 12.66% surprise); Canaccord Genuity reiterated a Buy with a $285 target while Morgan Stanley kept an Overweight rating but lowered its target to $250 from $265.

John Fesko, Natera, Inc.'s President and Chief Business Officer, reported a sale of 707 shares of the company's common stock on March 10, 2026, at a per-share price of $204.1327, for a total of about $144,321. The disposition, disclosed on a Form 4 filed with the Securities and Exchange Commission, reduced Fesko's direct holdings in Natera to 189,199 shares.

The filing states the sale was executed to satisfy tax obligations stemming from the vesting of Restricted Stock Units (RSUs). The previous day, March 9, 2026, Fesko received 1,774 shares of Natera common stock through the issuance of fully-vested RSUs.

The reported sale price of $204.1327 per share was above the company's then-current trading price of $196.61. The report notes that the stock is trading well above InvestingPro's Fair Value estimate and has been placed on InvestingPro's most overvalued list.

Financially, the $27.88 billion company has delivered 36% revenue growth over the last twelve months. Despite that top-line expansion, an InvestingPro Tip included with the firm's research notes that analysts do not expect the company to be profitable in the current year.

Investors and market observers also had fresh quarterly data to consider. Natera reported fourth-quarter 2025 revenue of $666 million, exceeding the $590.72 million that had been anticipated. That result represented a 12.66% surprise relative to expectations and was described in the filing as meaningful year-over-year growth.

Market responses from analysts accompanied the quarterly disclosure. Canaccord Genuity reiterated its Buy rating and kept a $285 price target, citing the company's strong quarter and higher test volumes across its business segments. Morgan Stanley maintained an Overweight rating but revised its price target to $250 from $265, attributing the change to a model update based on a discounted cash flow analysis following the earnings release.

Taken together, the insider transaction and the company's financial results present two distinct data points for investors: an executive sale tied to RSU tax requirements and a quarterly performance that outpaced consensus revenue estimates and drew continued analyst attention. For readers seeking additional detail, Natera's comprehensive Pro Research Report is available through InvestingPro for this company and more than 1,400 other U.S. equities.


Contextual note - The sale reported on March 10, 2026, is recorded on an SEC Form 4. The transaction follows the issuance of fully-vested RSUs on March 9, 2026, and reflects a tax-related disposition rather than an unsolicited open-market divestiture for non-specified reasons.

Risks

  • Insider sales to cover RSU-related tax obligations can be perceived by some investors as reducing insider shareholdings - this could influence investor sentiment in the equity markets.
  • Although Natera posted strong revenue growth (36% year-over-year), analysts do not expect the company to be profitable this year - profitability uncertainty affects valuation and investor expectations in the biotech and diagnostics sectors.
  • Price targets and analyst models can change after earnings - as evidenced by Morgan Stanley's adjustment based on a discounted cash flow model update, indicating sensitivity to updated assumptions in equity research.

More from Insider Trading

nLIGHT CEO Disposes of $1.12M in Shares as Stock Nears 52-Week Peak Mar 12, 2026 Reddit CTO Completes $1.29M Share Sale, Exercises Options and Donates Large Block of Stock Mar 12, 2026 Symbotic Director Sells Nearly $191K in Class A Shares as Stock Climbs Mar 11, 2026 Symbotic Director Sells $95K in Class A Stock Amid Unit Redemptions; Q1 Results Show Mixed Signals Mar 11, 2026 General Atlantic-Led Group Acquires $50.56M in Alkami Technology Stock Mar 11, 2026